These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 725958)

  • 21. Isolation and characterization of biologically active venom protein from sea snake Enhydrina schistosa.
    Damotharan P; Veeruraj A; Arumugam M; Balasubramanian T
    J Biochem Mol Toxicol; 2015 Mar; 29(3):140-7. PubMed ID: 25504782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A basic phospholipase A from the venom of the Australian king brown snake (Pseudechis australis) showing diverse activities against membranes.
    Sharp PJ; Berry SL; Spence I; Howden ME
    Comp Biochem Physiol B; 1989; 92(3):501-8. PubMed ID: 2706938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuromuscular blocking activity of two fractions isolated from the venom of the seasnake, Laticauda semifasciata.
    Harvey AL; Rodger IW; Tamiya N
    Toxicon; 1978; 16(1):45-50. PubMed ID: 622725
    [No Abstract]   [Full Text] [Related]  

  • 24. Purification and characterization of a phospholipase A2 from the venom of the coral snake, Micrurus fulvius microgalbineus (Brown and Smith).
    Possani LD; Alagòn AC; Fletcher PL; Varela MJ; Juliá JZ
    Biochem J; 1979 Jun; 179(3):603-6. PubMed ID: 475771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of phospholipase A activity in the neuromuscular paralysis produced by some components isolated from the venom of the seasnake, Laticauda semifasciata.
    Harvey AL; Tamiya N
    Toxicon; 1980; 18(1):65-9. PubMed ID: 7368227
    [No Abstract]   [Full Text] [Related]  

  • 26. Regeneration of mammalian skeletal muscle following the injection of the snake-venom toxin, taipoxin.
    Maltin CA; Harris JB; Cullen MJ
    Cell Tissue Res; 1983; 232(3):565-77. PubMed ID: 6883457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Danger in the reef: Proteome, toxicity, and neutralization of the venom of the olive sea snake, Aipysurus laevis.
    Laustsen AH; Gutiérrez JM; Rasmussen AR; Engmark M; Gravlund P; Sanders KL; Lohse B; Lomonte B
    Toxicon; 2015 Dec; 107(Pt B):187-96. PubMed ID: 26169672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemolytic assay for venom phospholipase A2.
    Vogel CW; Plückthun A; Müller-Eberhard HJ; Dennis EA
    Anal Biochem; 1981 Dec; 118(2):262-8. PubMed ID: 7337224
    [No Abstract]   [Full Text] [Related]  

  • 29. The relationship between high-affinity noncatalytic binding of snake venom phospholipases A2 to brain synaptic plasma membranes and their central lethal potencies.
    Rapuano BE; Yang CC; Rosenberg P
    Biochim Biophys Acta; 1986 Apr; 856(3):457-70. PubMed ID: 3964691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between catalysis and toxicological properties of three phospholipases A2 from elapid snake venoms.
    Fletcher JE; Rapuano BE; Condrea E; Yang CC; Rosenberg P
    Toxicol Appl Pharmacol; 1981 Jun; 59(2):375-88. PubMed ID: 7256775
    [No Abstract]   [Full Text] [Related]  

  • 31. Bioenergetic actions of beta-bungarotoxin, dendrotoxin and bee-venom phospholipase A2 on guinea-pig synaptosomes.
    Nicholls D; Snelling R; Dolly O
    Biochem J; 1985 Aug; 229(3):653-62. PubMed ID: 4052016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phospholipase A2 from cobra venom (Naja naja naja).
    Deems RA; Dennis EA
    Methods Enzymol; 1981; 71 Pt C():703-10. PubMed ID: 7278679
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of phospholipase A2 from cobra and bee venom on the presynaptic membrane.
    Magazanik LG; Gotgilf IM; Slavnova TI; Miroshnikov AI; Apsalon UR
    Toxicon; 1979; 17(5):477-88. PubMed ID: 516081
    [No Abstract]   [Full Text] [Related]  

  • 34. Phospholipase A2 activity of long-chain cardiotoxins in the venom of the banded krait (Bungarus fasciatus).
    Chang WC; Lee ML; Lo TB
    Toxicon; 1983; 21(1):163-5. PubMed ID: 6845380
    [No Abstract]   [Full Text] [Related]  

  • 35. Phospholipase A2-dependent effects of the venom from the New Guinean small-eyed snake Micropechis ikaheka.
    Kuruppu S; Isbister GK; Hodgson WC
    Muscle Nerve; 2005 Jul; 32(1):81-7. PubMed ID: 15803483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissociation of pharmacological and enzymatic activities of snake venom phospholipases A2 by modification of carboxylate groups.
    Rosenberg P; Condrea E; Rapuano BE; Soons KR; Yang CC
    Biochem Pharmacol; 1983 Dec; 32(23):3525-30. PubMed ID: 6651873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phospholipase A2 activity and substrate specificity of snake venom presynaptic toxins.
    Napias C; Heilbronn E
    Biochemistry; 1980 Mar; 19(6):1146-51. PubMed ID: 7370229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutralizing properties of LY315920 toward snake venom group I and II myotoxic phospholipases A
    Bryan-Quirós W; Fernández J; Gutiérrez JM; Lewin MR; Lomonte B
    Toxicon; 2019 Jan; 157():1-7. PubMed ID: 30447275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification, from Australian elapid venoms, and properties of phospholipases A which cause myoglobinuria in mice.
    Mebs D; Samejima Y
    Toxicon; 1980; 18(4):443-54. PubMed ID: 7210029
    [No Abstract]   [Full Text] [Related]  

  • 40. The toxicity and immunological properties of some sea-snake venoms with particular reference to that of Enhydrina schistosa.
    CAREY JE; WRIGHT EA
    Trans R Soc Trop Med Hyg; 1960 Jan; 54():50-67. PubMed ID: 13807689
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.